Financial News · Live Terminal

Page 333 of 344

Raymond James Initiates Milestone Pharmaceuticals at Strong Buy

Milestone Pharmaceuticals (MIST) has an average rating of buy and mean price target of $6.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MIST

Research12d ago

Citigroup Upgrades Nexstar Media Group to Buy From Neutral, Adjusts Price Target to $220 From $252

Nexstar Media Group (NXST) has an average rating of overweight and mean price target of $271.43, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$NXST

Research12d ago

Loop Capital Initiates Coverage on MACOM Technology Solutions With Buy Rating

MACOM Technology Solutions Holdings (MTSI) has an average rating of overweight and mean price target of $265.07, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$MTSI

Research12d ago

Needham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price Target

Lyell Immunopharma (LYEL) has an average rating of Buy and mean price target of $40.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$LYEL

Showing 6641-6660 of 6871

Financial News · Live Terminal

Raymond James Initiates Milestone Pharmaceuticals at Strong Buy

Citigroup Upgrades Nexstar Media Group to Buy From Neutral, Adjusts Price Target to $220 From $252

Loop Capital Initiates Coverage on MACOM Technology Solutions With Buy Rating

Needham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price Target

Raymond James Initiates Milestone Pharmaceuticals at Strong Buy

Citigroup Upgrades Nexstar Media Group to Buy From Neutral, Adjusts Price Target to $220 From $252

Loop Capital Initiates Coverage on MACOM Technology Solutions With Buy Rating

Needham & Co Initiates Coverage on Lyell Immunopharma With Strong Buy Rating, $44 Price Target

Raymond James Initiates United Therapeutics at Outperform

Goldman Sachs Upgrades Southern Copper to Neutral From Sell, Adjusts Price Target to $178 From $142.79

CIC Corporate & Institutional Banking Downgrades Sodexo to Neutral, Cuts PT

Svenska Handelsbanken Downgrades Getinge to Hold, Lowers PT

AlphaValue/Baader Europe Upgrades Heidelberg Materials to Add, Boosts PT

AlphaMena Downgrades Seera Group to Add Rating, Lifts PT

Elbit Systems Insider Sold Shares Worth $6,792,160, According to a Recent SEC Filing

SNB Capital Trims stc PT, Keeps Overweight Rating

Kepler Cheuvreux Upgrades Alstom to Hold Rating

Pareto Securities Downgrades Telenor to Hold, Lowers PT

MWB Research Downgrades Brenntag to Hold Rating

AlphaValue/Baader Europe Upgrades SAP to Buy Rating, Trims PT

Elbit Systems Insider Sold Shares Worth $6,036,982, According to a Recent SEC Filing

Citi Downgrades Leejam Sports to Neutral, Cuts PT

BSF Capital Downgrades Luberef to Hold, Lifts PT

Oddo BHF Upgrades Dino Polska to Outperform, Reduces PT